Simulate Real-World Payer Decisions Before You Go to Market
AI-enabled payer personas built from real qualitative research to simulate how payers evaluate evidence, assess risk, and make coverage decisions—without the timeline of traditional studies.
The Challenge
Payer insight is critical to access strategy, but traditional research does not always match the pace of decision-making.
Full qualitative payer studies can take 12 to 15 weeks. Launch timelines often require faster, directional insight. Teams are left making key decisions without a clear view of how payers will evaluate their product.
At the same time, payer decisions follow consistent patterns. Coverage and reimbursement are shaped by how payers assess clinical and economic evidence, budget impact and risk, comparator performance, and perceived unmet need.
The challenge is not a lack of insight. It is accessing the right insight at the right time.
The Solution
AI-enabled payer personas that simulate how real payers evaluate products in specific scenarios.
Built from Magnolia Market Access’ proprietary qualitative research, these personas reflect how payers assess clinical and economic evidence, weigh risk, and make coverage decisions. These simulations are grounded in consistent, real-world evaluation patterns observed across payer types.
Instead of waiting months for primary research, teams can test value narratives in realistic payer contexts, anticipate likely objections and access barriers, explore how decisions vary by payer type, and identify evidence gaps early.
How it works:
Define the Evaluation Scenario
Select the scenario shaping payer evaluation, such as a crowded class, first-in-class launch, label expansion, or biosimilar entry.
Select Target Payer Profiles
Tailor by organization type, role, geography, and book of business.
Apply Payer Archetypes
Simulate common decision lenses, including budget-focused, outcomes-driven, comparator-focused, and patient-centered perspectives.
Simulate Decision Pathways
Model how payers evaluate products, including what drives scrutiny, skepticism, and coverage decisions.
Key Use Cases
What Clients Receive
Outputs are structured to reflect how payers evaluate products and to directly inform access and evidence decisions.
Simulated payer feedback tied to specific decision scenarios.
Clear articulation of risks, objections, and evidence gaps.
Comparative insights across payer types.
Strategic recommendations to guide access and evidence planning.
Why This Is Different
Not traditional research.
No recruitment timelines or fieldwork delays.
Not generic AI.
Built on real payer interviews and structured decision patterns.
Not just outputs.
Insights are interpreted through market access expertise to inform strategy.
When to Use This
This solution is most valuable when:
Understand how payers are likely to evaluate your product before they do.
Request a Discussion
"*" indicates required fields
Whether you are testing your value narrative, planning for launch, or anticipating payer decisions, Magnolia Market Access helps you make more informed, confident strategy decisions.
Contact us to explore how this approach can support your strategy.